The benzodiazepine stigma persists.

[1]  David L Streiner,et al.  Benzodiazepine use and driving: a meta-analysis. , 2009, The Journal of clinical psychiatry.

[2]  A. Engeland,et al.  Road traffic accident risk in patients with diabetes mellitus receiving blood glucose‐lowering drugs. Prospective follow‐up study , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[3]  R. Hubbard,et al.  American Journal of Epidemiology Practice of Epidemiology Use of Self-controlled Analytical Techniques to Assess the Association between Use of Prescription Medications and the Risk of Motor Vehicle Crashes , 2022 .

[4]  H. Walls,et al.  The incidence of Zolpidem use in suspected DUI drivers in Miami-Dade Florida: a comparative study using immunalysis Zolpidem ELISA KIT and gas chromatography-mass spectrometry screening. , 2008, Journal of analytical toxicology.

[5]  Anders Engeland,et al.  Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. , 2008, The Journal of clinical psychiatry.

[6]  Thomas E. Nichols,et al.  Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder. , 2007, Archives of general psychiatry.

[7]  J. Ramaekers,et al.  Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. , 2006, British journal of clinical pharmacology.

[8]  John R Knight,et al.  Nonmedical use of prescription opioids among U.S. college students: prevalence and correlates from a national survey. , 2005, Addictive behaviors.

[9]  J. Ramaekers,et al.  Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. , 2005, The Journal of clinical psychiatry.

[10]  H. Möller,et al.  Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls. , 2005, Journal of psychiatric research.

[11]  R. Croft,et al.  The effects of dexamphetamine on simulated driving performance , 2005, Psychopharmacology.

[12]  J. Verster,et al.  Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  I. Lucki,et al.  Chronic use of benzodiazepines and psychomotor and cognitive test performance , 2004, Psychopharmacology.

[14]  E. Hollander,et al.  WCA Recommendations for the Long-Term Treatment of Panic Disorder , 2003, CNS Spectrums.

[15]  M. Keller,et al.  Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? , 2003, The American journal of psychiatry.

[16]  Philip Swann,et al.  The incidence of drugs in drivers killed in Australian road traffic crashes. , 2003, Forensic Science International.

[17]  F. Verhey,et al.  A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic , 2002, Psychopharmacology.

[18]  J. Gorman,et al.  Management of treatment-refractory panic disorder. , 2001, Psychopharmacology bulletin.

[19]  J. Rosenbaum,et al.  Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. , 1998, Psychopharmacology bulletin.

[20]  J. Rosenbaum,et al.  Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. , 1993, Journal of clinical psychopharmacology.